Word

AVIDITY BIOSCIENCES

Status

Registered

Status Code

700

Status Date

Tuesday, September 15, 2020

Serial Number

88808590

Registration Number

6151953

Registration Date

Tuesday, September 15, 2020

Mark Type

3000

Filing Date

Monday, February 24, 2020

Published for Opposition

Tuesday, June 30, 2020

Trademark Owner History

Avidity Biosciences, Inc. - Original Registrant

Classifications

42 Research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research services for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; development of pharmaceutical preparations and medicines, namely, the development of oligonucleotide-based therapeutics

The mark consists of the wording "AVIDITY" in an all-caps font where the "A" is formed by a down-facing angle. The wording "BIOSCIENCES" appears below in a smaller all-caps font. To the left of the wording is a highly stylized design of two curved ribbons forming a diamond or partial double-helix shape.
Color is not claimed as a feature of the mark.
"BIOSCIENCES"

Trademark Events

Feb 18, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Feb 18, 2022

Teas Change Of Correspondence Received

Feb 18, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 18, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 18, 2022

Teas Change Of Owner Address Received

Sep 15, 2020

Registered-Principal Register

Jun 30, 2020

Official Gazette Publication Confirmation E-Mailed

Jun 30, 2020

Published For Opposition

Jun 10, 2020

Notification Of Notice Of Publication E-Mailed

May 28, 2020

Teas Response To Office Action Received

May 28, 2020

Approved For Pub - Principal Register

May 28, 2020

Examiner's Amendment Entered

May 28, 2020

Notification Of Examiners Amendment E-Mailed

May 28, 2020

Examiners Amendment E-Mailed

May 28, 2020

Examiners Amendment -Written

May 20, 2020

Notification Of Non-Final Action E-Mailed

May 20, 2020

Non-Final Action E-Mailed

May 20, 2020

Non-Final Action Written

May 12, 2020

Assigned To Examiner

Feb 28, 2020

Notice Of Design Search Code E-Mailed

Feb 27, 2020

New Application Office Supplied Data Entered In Tram

Feb 27, 2020

New Application Entered In Tram